Global Endometriosis Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

By Drug Class;

Hormone Therapy and Analgesics.

By Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn159139082 Published Date: May, 2022 Updated Date: February, 2025

Introduction

Global Endometriosis Therapeutics Market (USD Million), 2018 - 2028

In the year 2021, the Global Endometriosis Therapeutics Market was valued at USD 1,105.50 million. The size of this market is expected to increase to USD 2,683.26 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 13.5%.

Endometriosis, a chronic condition affecting women of reproductive age, occurs when tissue similar to the lining of the uterus grows outside the uterus, commonly causing pelvic pain and infertility. It is estimated to affect around 10% of women worldwide, with varying degrees of severity. The global endometriosis therapeutics market is witnessing significant growth due to increasing awareness, improved diagnostics, and a rising number of diagnosed cases.

One of the key drivers of market growth is the expanding research and development efforts aimed at developing novel treatment options. Traditional therapies such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies have been the mainstay of endometriosis management. However, there remains an unmet need for more effective and tolerable treatments, particularly for women with severe symptoms or those who do not respond well to existing therapies.

There has been a surge in the development of targeted therapies aimed at addressing specific pathways involved in the pathogenesis of endometriosis. These include drugs targeting hormonal receptors, angiogenesis, and inflammatory pathways. Additionally, advancements in surgical techniques, such as minimally invasive procedures and robotic-assisted surgery, have improved treatment outcomes and contributed to the growth of the market.

Increased healthcare expenditure, growing patient advocacy, and supportive government initiatives aimed at improving women's health have further fueled market expansion. However, challenges such as diagnostic delays, limited access to specialized care in certain regions, and the stigma associated with menstrual health disorders continue to hinder market growth. Nonetheless, with ongoing research and development efforts and a growing emphasis on personalized medicine, the global endometriosis therapeutics market is poised for continued growth in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By Region
  4. Global Endometriosis Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements in treatment options
        2. Rising awareness and diagnosis rates
        3. Growing demand for effective therapies
        4. Increasing research and development investments
      2. Restraints
        1. Limited understanding of disease mechanisms
        2. High cost of treatment options
        3. Lack of definitive diagnostic tools
        4. Adverse effects of current therapies
      3. Opportunities
        1. Emerging personalized medicine approaches
        2. Expansion into untapped geographical markets
        3. Development of novel targeted therapies
        4. Collaborations for clinical trial advancements
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Endometriosis Therapeutics Market, By Drug Class, 2020 - 2030 (USD Million)
      1. Hormone Therapy
      2. Analgesics
    2. Global Endometriosis Therapeutics Market, By Distribution Channel, 2020 - 2030 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Global Endometriosis Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. AbbVie Inc
      2. Bayer AG
      3. Pfizer Inc
      4. AstraZeneca plc
      5. Johnson & Johnson
      6. Takeda Pharmaceutical Company Limited
      7. Myovant Sciences Ltd
      8. AbbVie Inc
      9. Astellas Pharma Inc
      10. Neurocrine Biosciences, Inc
  7. Analyst Views
  8. Future Outlook of the Market